#BioLIVE2026 | Pharma & Biotech

BioFormulate Live 2026 brings Europe’s formulation, stability, and drug-delivery leaders together in London to shape the next generation of high-performance biologics.

A high-impact leadership forum solving the toughest challenges in biologics formulation and delivery

‍

BioFormulate Live 2026 brings Europe’s formulation, stability, and drug-delivery leaders together for an intensive deep dive into the science shaping tomorrow’s biologics. Across 3 focused streams - RNA Therapeutics & Development, Vaccine Innovation, and Biologics Formulation & Delivery - the programme explores pioneering systems, stability strategies, and next-gen delivery technologies redefining biopharmaceutical development.

‍

Europe’s landscape for biologics formulation and delivery is evolving at unprecedented speed. With RNA medicines, advanced vaccines, and complex biologics becoming central to global health, the pressure has never been greater to engineer drug products that are more stable, more manufacturable, and more patient-centric. BioFormulate Live 2026 is designed precisely for that mission.

This is the must-attend technical forum for professionals working to improve everything from drug stability and bioavailability to developability, scalability, manufacturability, and regulatory alignment.

‍

Here, you’ll gain actionable insight into:

• Optimising formulation strategies for complex biologics
• Engineering advanced delivery systems for improved performance
• Strengthening product stability through innovative excipients and techniques
• Accelerating development with automation, modelling, and analytical advancements
• Meeting evolving global regulatory expectations with confidence